Laura Stapleton is a seasoned Medical Affairs professional with over 20 years of experience, currently serving as a Senior Clinical Scientist at ICON Strategic Solutions. In her role, Laura leverages her extensive expertise in clinical trial management and project management to drive the success of...
Laura Stapleton is a seasoned Medical Affairs professional with over 20 years of experience, currently serving as a Senior Clinical Scientist at ICON Strategic Solutions. In her role, Laura leverages her extensive expertise in clinical trial management and project management to drive the success of pivotal clinical studies, particularly focusing on pembrolizumab, a key immunotherapy agent developed by Merck. Her work in External Collaborations is instrumental in fostering partnerships that enhance the efficiency and effectiveness of clinical research, ensuring that studies are executed with precision and aligned with regulatory standards.
Laura’s proficiency in project management is complemented by her strong organizational skills and financial planning acumen, allowing her to oversee complex clinical trials from inception through to completion. She excels in business process improvement, consistently identifying opportunities to streamline operations and enhance productivity within cross-functional teams. Her collaborative approach not only facilitates seamless communication among stakeholders but also cultivates an environment of learning agility, where innovative solutions can thrive.
In addition to her technical skills, Laura is adept at new product launch planning and execution, bringing a strategic mindset that aligns clinical objectives with broader business goals. Her deep understanding of drug development processes, combined with her commitment to teamwork, positions her as a key player in advancing the pharmaceutical landscape. As she continues to contribute to groundbreaking studies, Laura remains dedicated to improving patient outcomes through the effective delivery of clinical research initiatives.
